Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B

10.1016/j.jhep.2008.12.019

Saved in:
Bibliographic Details
Main Authors: Zeuzem, S., Gane, E., Liaw, Y.-F., Lim, S.G., DiBisceglie, A., Buti, M., Chutaputti, A., Rasenack, J., Hou, J., O'Brien, C., Nguyen, T.T., Jia, J., Poynard, T., Belanger, B., Bao, W., Naoumov, N.V.
Other Authors: MEDICINE
Format: Article
Published: 2016
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/129754
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-129754
record_format dspace
spelling sg-nus-scholar.10635-1297542023-10-30T20:39:32Z Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B Zeuzem, S. Gane, E. Liaw, Y.-F. Lim, S.G. DiBisceglie, A. Buti, M. Chutaputti, A. Rasenack, J. Hou, J. O'Brien, C. Nguyen, T.T. Jia, J. Poynard, T. Belanger, B. Bao, W. Naoumov, N.V. MEDICINE Chronic hepatitis B GLOBE trial Lamivudine Predictors Telbivudine 10.1016/j.jhep.2008.12.019 Journal of Hepatology 51 1 11-20 JOHEE 2016-11-08T09:58:11Z 2016-11-08T09:58:11Z 2009-07 Article Zeuzem, S., Gane, E., Liaw, Y.-F., Lim, S.G., DiBisceglie, A., Buti, M., Chutaputti, A., Rasenack, J., Hou, J., O'Brien, C., Nguyen, T.T., Jia, J., Poynard, T., Belanger, B., Bao, W., Naoumov, N.V. (2009-07). Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B. Journal of Hepatology 51 (1) : 11-20. ScholarBank@NUS Repository. https://doi.org/10.1016/j.jhep.2008.12.019 01688278 http://scholarbank.nus.edu.sg/handle/10635/129754 000267713400004 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Chronic hepatitis B
GLOBE trial
Lamivudine
Predictors
Telbivudine
spellingShingle Chronic hepatitis B
GLOBE trial
Lamivudine
Predictors
Telbivudine
Zeuzem, S.
Gane, E.
Liaw, Y.-F.
Lim, S.G.
DiBisceglie, A.
Buti, M.
Chutaputti, A.
Rasenack, J.
Hou, J.
O'Brien, C.
Nguyen, T.T.
Jia, J.
Poynard, T.
Belanger, B.
Bao, W.
Naoumov, N.V.
Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
description 10.1016/j.jhep.2008.12.019
author2 MEDICINE
author_facet MEDICINE
Zeuzem, S.
Gane, E.
Liaw, Y.-F.
Lim, S.G.
DiBisceglie, A.
Buti, M.
Chutaputti, A.
Rasenack, J.
Hou, J.
O'Brien, C.
Nguyen, T.T.
Jia, J.
Poynard, T.
Belanger, B.
Bao, W.
Naoumov, N.V.
format Article
author Zeuzem, S.
Gane, E.
Liaw, Y.-F.
Lim, S.G.
DiBisceglie, A.
Buti, M.
Chutaputti, A.
Rasenack, J.
Hou, J.
O'Brien, C.
Nguyen, T.T.
Jia, J.
Poynard, T.
Belanger, B.
Bao, W.
Naoumov, N.V.
author_sort Zeuzem, S.
title Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
title_short Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
title_full Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
title_fullStr Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
title_full_unstemmed Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B
title_sort baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis b
publishDate 2016
url http://scholarbank.nus.edu.sg/handle/10635/129754
_version_ 1781790693420695552